| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 62.989 | 99.473 | 110.081 | 167.724 | 161.286 | 243.769 | 390.316 | 483.788 | 390.279 |
| Total Income - EUR | - | 62.994 | 99.583 | 110.187 | 168.277 | 165.651 | 243.958 | 396.699 | 491.211 | 391.115 |
| Total Expenses - EUR | - | 9.494 | 32.998 | 53.945 | 76.847 | 71.013 | 124.022 | 294.989 | 348.783 | 377.702 |
| Gross Profit/Loss - EUR | - | 53.500 | 66.585 | 56.242 | 91.430 | 94.638 | 119.936 | 101.710 | 142.428 | 13.413 |
| Net Profit/Loss - EUR | - | 52.870 | 65.589 | 55.142 | 89.748 | 93.129 | 117.789 | 97.823 | 138.106 | 9.064 |
| Employees | - | 1 | 2 | 5 | 5 | 5 | 5 | 7 | 3 | 8 |
Check the financial reports for the company - Retinol Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 6.825 | 6.552 | 19.666 | 16.799 | 59.879 | 39.845 | 178.333 | 147.420 | 118.700 |
| Current Assets | - | 46.855 | 61.887 | 102.762 | 77.255 | 168.650 | 340.649 | 312.923 | 86.795 | 30.352 |
| Inventories | - | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 1.136 |
| Receivables | - | 0 | 55 | 282 | 190 | 93 | 47.112 | 98.930 | 19.257 | 26.307 |
| Cash | - | 46.855 | 61.832 | 102.480 | 77.056 | 168.557 | 293.537 | 213.993 | 67.538 | 2.909 |
| Shareholders Funds | - | 53.093 | 65.902 | 119.834 | 91.455 | 182.850 | 296.584 | 98.112 | 170.172 | 9.372 |
| Social Capital | - | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | 587 | 2.537 | 2.593 | 2.599 | 45.679 | 100.379 | 393.450 | 64.264 | 140.032 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Retinol Srl